Skip to main content

Table 2 Summary of key data from eight reported cases of urachal adenocarcinoma metastatic to the ovaries

From: Surgical and chemotherapeutic experience regarding a urachal carcinoma with repeated relapse: case report and literature review

Reference Metastasis site Age Serum tumor marker Status with primary urachal carcinoma Pathology Immunohistochemistry (positive or negative) Treatment Follow-up result
[15] Right ovary 50 CEA 27.9 ng/m Simultaneous finding Not available - Surgery Not available
[16] Both ovaries, bone, lymph nodes 50 CEA 27.9 ng/ml Simultaneous finding High-grade mucinous adenocarcinoma Cytokeratin 20 and CEA, cytokeratin 7 Surgery and irradiation Alive with disease (6 months)
[17] Right ovary, peritoneum, sigmoid colon 54 - Simultaneous finding Moderately differentiated mucinous adenocarcinoma Surgery and chemotherapy Alive with disease (55 months)
[18] Both ovaries, abdominal wall, colon mass, uterosacral ligament, bladder 64 Normal Secondary metastasis Borderline malignant mucinous adenocarcinoma Surgery and chemotherapy Alive with disease (3 months)
[19] Both ovaries, bladder 39 Normal Secondary metastasis Well-differentiated mucinous adenocarcinoma Surgery and chemotherapy Died of disease (38 months)
[20] Both ovaries, peritoneum, bone 26 - Secondary metastasis - Surgery and chemotherapy Died of disease (26 months)
[21] Left ovary, right lung 30 - Secondary metastasis Well-differentiated mucinous adenocarcinoma Surgery and chemotherapy Alive without disease (11 years)
[22] Both ovaries 72 - Pre-finding Moderately differentiated mucinous adenocarcinoma Surgery and chemotherapy Alive with disease (36 months)